Hakutulokset - Jorge Máspero
- Näytetään 1 - 20 yhteensä 46 tuloksesta
- Siirry seuraavalle sivulle
-
1
-
2
-
3
-
4
-
5
Relative potency in SPT of solution and tablet SLIT allergen extracts of Timothy grass pollen from 2 European manufacturers compared to a US reference extract Tekijä Désirée Larenas‐Linnemann, Robert E. Esch, Jaswinder Singh, Juan José Matta, Nelson Augusto Rosário Filho, Jorge Máspero, Alexandra Michels, Ralph Mösges
Julkaistu 2015Artigo -
6
Relative Potency in SPT of Solution and Tablet SLIT Allergen Extracts of Timothy Grass Pollen from 2 European Manufacturers Compared to a US Reference Extract Tekijä Désirée E.S. Larenas Linnemann, Robert E. Esch, Jaswinder Singh, Juan José Matta, Nelson Augusto Rosário, Jorge Máspero, Alexandra Michels, Ralph Mösges
Julkaistu 2015Artigo -
7
Management of CRSwNP in Latin America: A multidisciplinary consensus from an expert working group Tekijä Jorge Máspero, Wilma Terezinha Anselmo‐Lima, David Bedoya, Marcos Alejandro Jiménez-Chobillón, Javier Ospina, Renato Roithmann, Andrés Sadek Gonzalez, Ricardo Silva Rueda
Julkaistu 2024Artigo -
8
Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America Tekijä Jorge Máspero, José Roberto Jardim, Alvaro Aranda, Paolo Tassinari C, Sandra Nora González Díaz, Raúl H Sansores, J.J. Moreno-Cantú, James E. Fish
Julkaistu 2013Artigo -
9
Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial Tekijä Andrew Menzies‐Gow, Jonathan Corren, Elisabeth H. Bel, Jorge Máspero, Liam G. Heaney, Mark Gurnell, Peter Wessman, Ubaldo J. Martin, Shahid Siddiqui, Esther Garcia Gil
Julkaistu 2019Artigo -
10
Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolle... Tekijä Christian Geßner, Oliver Kornmann, Jorge Máspero, Richard N. van Zyl-Smit, Matthias Krüll, Anna Salina, Pritam Gupta, Sebastien Bostel, Sebastian Fucile, Lorena Garcia Conde, Pascal Pfister
Julkaistu 2020Artigo -
11
Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma... Tekijä Huib A.M. Kerstjens, Jorge Máspero, Kenneth R. Chapman, Richard N. van Zyl-Smit, Motoi Hosoe, Ana-Maria Tanase, Catherine Lavecchia, Abhijit Pethe, Xu Shu, Peter D’Andrea
Julkaistu 2020Artigo -
12
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized pl... Tekijä Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert, Leda Mannent, Giorgio Walter Canonica, Joseph K. Han, Jorge Máspero, César Picado, Nadia Daizadeh, Benjamin Ortiz, Yongtao Li, Marcella Ruddy, Elizabeth Laws, Nikhil Amin
Julkaistu 2021Artigo -
13
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE) Tekijä Jorge Máspero, Martti Antila, A. Deschildre, Leonard B. Bacharier, Arman Altincatal, Elizabeth Laws, Eric Mortensen, Amr Radwan, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin
Julkaistu 2024Artigo -
14
Type 2 inflammation in asthma and other airway diseases Tekijä Jorge Máspero, Yochai Adir, Mona Al‐Ahmad, C.A. Celis-Preciado, Federico D. Colodenco, Pedro Giavina‐Bianchi, Hani Lababidi, Olivier Ledanois, Bassam Mahoub, Diahn‐Warng Perng, Juan Carlos Vázquez-García, Arzu Yorgancıoğlu
Julkaistu 2022Revisão -
15
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma Tekijä Sumita Khatri, Wendy C. Moore, Peter G. Gibson, Richard Leigh, Arnaud Bourdin, Jorge Máspero, Manuel Barros, Roland Buhl, Peter Howarth, Frank C. Albers, Eric Bradford, M Gilson, Robert G. Price, Steven W. Yancey, Héctor Ortega
Julkaistu 2018Artigo -
16
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count Tekijä Claus Bachert, Ana R. Sousa, Joseph K. Han, Rodney J. Schlosser, Leigh J. Sowerby, Claire Hopkins, Jorge Máspero, Steven G. Smith, Oliver Kante, Despina E. Karidi-Andrioti, Bhabita Mayer, Robert Chan, Steve Yancey, Adam Chaker
Julkaistu 2022Artigo -
17
Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study Tekijä Jorge Máspero, Guido Cardona, Patricia Schonffeldt, Alberto Tolcachier, Sandra Nora González Díaz, Anahí Yáñez, Clóvis Eduardo Santos Galvão, Jérôme Msihid, Rebecca Gall, Shahid Siddiqui, Paul J. Rowe, Yamo Deniz, Juby A. Jacob‐Nara, Michel Djandji
Julkaistu 2022Artigo -
18
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Se... Tekijä William W. Busse, Jorge Máspero, Klaus F. Rabe, Alberto Papi, Sally E. Wenzel, Linda B. Ford, Ian Pavord, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi, Nikhil Amin, Bolanle Akinlade, Laurent Eckert, Jingdong Chao, Neil M.H. Graham, Ariel Teper
Julkaistu 2018Artigo -
19
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma Tekijä Tanya M. Laidlaw, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W. Hellings, Joaquim Mullol, Jorge Máspero, Philippe Gevaert, Mei Zhang, Xuezhou Mao, Asif Khan, Siddhesh Kamat, Naimish Patel, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, Leda Mannent
Julkaistu 2021Artigo -
20
Elimination of Oral Corticosteroids (OCS) with Benralizumab Treatment in OCS-Dependent Asthmatics Using a Rapid, Personalized Algorithm: The PONENTE Trial Tekijä Andrew Menzies‐Gow, Mark Gurnell, Liam G. Heaney, Jonathan Corren, Elisabeth H. Bel, Jorge Máspero, Timothy Harrison, David J. Jackson, David Price, Njira Lugogo, James L. Kreindler, Annie Burden, A de Giorgio Miller, Ubaldo J. Martin, Kelly Padilla, Esther Garcia Gil
Julkaistu 2021Artigo
Työkalut:
Liittyvät aiheet
Medicine
Asthma
Internal medicine
Immunology
Pathology
Dupilumab
Pediatrics
Intensive care medicine
Alternative medicine
Dermatology
Eosinophil
Mepolizumab
Benralizumab
Family medicine
Gastroenterology
Placebo
Adverse effect
Allergy
Antibody
Chronic rhinosinusitis
Corticosteroid
Nasal polyps
Bronchodilator
Computer science
Disease
Immunoglobulin E
Latin Americans
Law
Linguistics
Nursing